Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit
NCT01921452 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 283
Last updated 2014-11-25
Summary
This is a Phase 4, single-center, open-label, interventional study, wherein all enrolled subjects will be tested for Thyroid Stimulating Hormone (TSH) by using the quantitative and the qualitative Point-of-Care (POC) TSH test kits and the third generation TSH test kit at the same time.
Conditions
Interventions
- DEVICE
-
Quantitative POC TSH Kit
A drop (approximately 30 microliter \[mcL\]) of blood will be taken from subject's fingertip to test TSH quantitatively by using the quantitative POC TSH test kit according to the product specification on Day 1 to Day 5.
- DEVICE
-
Qualitative POC TSH Kit
A drop (approximately 30 mcL) of blood will be taken from subject's fingertip to test TSH qualitatively by using the qualitative POC TSH test kit according to the product specification on Day 1 to Day 5.
- DEVICE
-
Third generation TSH Kit
One milliliter (mL) of subject's venous blood will be taken to test both qualitative and quantitative TSH levels, by using the third generation TSH test kit on Day 1 to Day 5.
Sponsors & Collaborators
-
Merck KGaA, Darmstadt, Germany
lead INDUSTRY
Principal Investigators
-
Medical Responsible · Merck Serono Limited, UK
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2014-02-28
- Completion
- 2014-02-28
Countries
- China
Study Locations
More Related Trials
-
A Study of T3 Therapy in Patients With Hypothyroidism
NCT01800617 ·Status: COMPLETED ·Phase: PHASE2
-
The Relationship Between Serum rT3 Concentrations, T3/T4 Ratio, and Symptoms/Quality of Life in Treated Hypothyroid Patients
NCT05015725 ·Status: COMPLETED
-
Validation of a New TSH Test
NCT01997554 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients
NCT04137185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Screening of Subclinical Hypothyroidism in Pregnant Women
NCT05801822 ·Status: UNKNOWN
-
Levothyroxine Intervention in Pregnant Women with TSH (2.5 MIU/L-upper Limit of Reference Range) and Negative Thyroid Peroxidase Antibody
NCT06653907 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Biosignals by Wearable Devices in Hypothyroidism
NCT04332770 ·Status: COMPLETED
-
Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism
NCT00531713 ·Status: COMPLETED ·Phase: PHASE4
-
Central Hypothyroidism, a Novel Laboratory Measurement
NCT01280292 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism
NCT06724224 ·Status: RECRUITING
-
Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients
NCT03053115 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter
NCT00275171 ·Status: COMPLETED ·Phase: PHASE2
-
Maternal Thyroid Function in Early Pregnancy and Their Relationship With Gestational Diabetes Mellitus
NCT02555332 ·Status: COMPLETED
-
The Establish of Specific Reference Ranges for Thyroid Tests in Pregnant Women
NCT02966405 ·Status: UNKNOWN
-
Thyroxine Titration Study
NCT00111735 ·Status: UNKNOWN ·Phase: PHASE4
-
Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France
NCT01197183 ·Status: COMPLETED
-
A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism
NCT05412979 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
NCT03096613 ·Status: UNKNOWN ·Phase: PHASE4
-
Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism
NCT02317926 ·Status: UNKNOWN ·Phase: NA
-
Preconceptional Thyroid Screening and Childhood Nerocognitive Function
NCT01744743 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment
NCT03969108 ·Status: COMPLETED ·Phase: PHASE4
-
Recovery Rate in Secondary Hypothyroidism
NCT05276856 ·Status: RECRUITING
-
Serum Thyroid Function After Iodinated Contrast Administration
NCT05786846 ·Status: UNKNOWN
-
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
NCT01739972 ·Status: UNKNOWN ·Phase: NA
-
Thyroid Profiles in Patients With Acute Illness
NCT05980923 ·Status: WITHDRAWN